Shandong Pharmaceutical Glass to host Q3 2025 earnings briefing

Shandong Pharmaceutical Glass Co., Ltd. (SSE:600529) will host a third-quarter 2025 earnings briefing on Monday, November 17, 2025, from 09:00 to 10:00. The online event will be held via the Shanghai Stock Exchange Roadshow Center, accessible at https://roadshow.sseinfo.com/. This briefing follows the release of the company's Q3 2025 report on October 28, 2025, and aims to provide investors with a comprehensive understanding of its operating results and financial condition.

Investors can submit questions in advance from Monday, November 10, 2025, until 16:00 on Friday, November 14, 2025, through the "Question Pre-collection" section on the Roadshow Center website or by emailing sdyb@pharmglass.com. The company's management, including general manager Zhang Jun, board secretary Zhao Haibao, and CFO Song Yizhao, along with independent directors, will be present to interact with investors and answer questions within the scope of information disclosure regulations.

Further details regarding the briefing, including a review of the proceedings and key content, will be available on the Shanghai Stock Exchange Roadshow Center website after the event. For inquiries, investors may contact Ru Bo or Yi Xixin at 0533-3259016 or via email at sdyb@pharmglass.com.